TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UroMedical Väst AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
63,049
|
69,294
|
59,387 |
| Financial expenses |
10,329
|
422
|
4,996 |
| Earnings before taxes |
-3,899
|
11,113
|
-419 |
| EBITDA |
7,384
|
12,083
|
5,667 |
| Total assets |
17,977
|
22,178
|
29,161 |
| Current assets |
9,120
|
9,570
|
17,397 |
| Current liabilities |
7,472
|
7,308
|
15,275 |
| Equity capital |
9,644
|
14,024
|
13,096 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
22
|
22
|
22 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.6%
|
63.2%
|
44.9% |
| Turnover per employee |
2,866
|
3,150
|
2,699 |
| Profit as a percentage of turnover |
-6.2%
|
16.0%
|
-0.7% |
| Return on assets (ROA) |
35.8%
|
52.0%
|
15.7% |
| Current ratio |
122.1%
|
131.0%
|
113.9% |
| Return on equity (ROE) |
-40.4%
|
79.2%
|
-3.2% |
| Change turnover |
-7,494
|
5,693
|
2,319 |
| Change turnover % |
-11%
|
9%
|
4% |
| Chg. No. of employees |
0
|
0
|
3 |
| Chg. No. of employees % |
0%
|
0%
|
16% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.